Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
YesterdayDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
YesterdayRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
YesterdayThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
YesterdayBuffalo Potash Files Annual Information Form and New Technical Report
YesterdayIonik Announces 30-Day Extension of Senior Debt Facility
Crescita Therapeutics, Inc. logo

Crescita Therapeutics, Inc.

About

0.75CAD-0.01 -1.32%
Closed • Updated at 16:32 GMT+00:00
Market Cap$10.13M
Volume3.6K
Beta-2.08
RSI61.66
Gross Margin49.22%
Health TechnologyPharmaceuticals: Major

Crescita Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 20 2026
Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement
May 14 2026
Crescita Obtains Shareholder Approval To Be Acquired By ClinActiv Holdings
May 11 2026
Crescita Reports First Quarter 2026 Results
Apr 22 2026
Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings
Mar 31 2026
Crescita Reports Q4 and Fiscal 2025 Results

Community Chat

Ask AI

Try asking
6ix6ixAIEvents